Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,157 | -15,930 | -5,184 | N/A | -5,551 |
| Depreciation Amortization | 139 | 100 | 60 | N/A | 239 |
| Accounts receivable | N/A | -161 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -249 | 404 | -288 | N/A | -312 |
| Other Working Capital | 134 | 896 | 85 | N/A | 741 |
| Other Operating Activity | 12,209 | 11,218 | 3,388 | 0 | 1,234 |
| Operating Cash Flow | $-4,924 | $-3,473 | $-1,939 | $N/A | $-3,650 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -117 | -111 | -74 | N/A | N/A |
| Purchase Sale Intangibles | -600 | -420 | -261 | N/A | -410 |
| Other Investing Activity | -600 | -420 | -261 | 0 | -410 |
| Investing Cash Flow | $-717 | $-531 | $-335 | $N/A | $-410 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | N/A | 10,842 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -2,187 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $8,655 |
| Beginning Cash Position | 6,111 | 6,111 | 6,111 | N/A | 1,602 |
| End Cash Position | 470 | 2,108 | 3,837 | N/A | 6,198 |
| Net Cash Flow | $-5,641 | $-4,004 | $-2,274 | $N/A | $4,596 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,924 | -3,473 | -1,939 | N/A | -3,650 |
| Capital Expenditure | -117 | -111 | -74 | N/A | N/A |
| Free Cash Flow | -5,041 | -3,584 | -2,014 | 0 | -3,650 |